Frank Rimerman Advisors’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$231K Buy
426
+43
+11% +$22.2K 0.01% 573
2026
Q2
$208K Sell
383
-5
-1% -$2.82K 0.01% 594
2026
Q1
$230K Buy
+388
New +$193K 0.02% 549

Other funds holding UTHR

Frank Rimerman Advisors's UTHR Position: Q3 2026 in Review

Frank Rimerman Advisors increased its United Therapeutics (UTHR) stake by 11% in Q3 2026, buying an estimated $22.2K and bringing the position to 426 shares worth $231K. The position accounts for 0.01% of the portfolio, ranked #573.

Frank Rimerman Advisors first reported a position in UTHR in Q1 2026 and has held it in 3 quarters since. 838 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

  • Frank Rimerman Advisors held 426 shares of United Therapeutics worth $231K as of Q3 2026.
  • Frank Rimerman Advisors bought 43 United Therapeutics shares in Q3 2026, an estimated $22.2K.
  • United Therapeutics made up 0.01% of Frank Rimerman Advisors's portfolio in Q3 2026, its #573 holding.
  • Frank Rimerman Advisors first reported a position in United Therapeutics in Q1 2026 and has held it in 3 quarters since.
  • 838 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on Frank Rimerman Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.